| Sep 07, 2023 |
Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic Focus
|
|
| Aug 21, 2023 |
Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
|
|
| Aug 04, 2023 |
Adamis Pharmaceuticals Announces Closing of $8.0 Million Public Offering
|
|
| Aug 02, 2023 |
Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering
|
|
| Jul 28, 2023 |
Adamis Pharmaceuticals to Fund ZIMHI® Clinical Study with University of Leiden Opioid Expert
|
|
| Jun 26, 2023 |
Adamis Pharmaceuticals Announces NIH Grant Funding for the Treatment of Alcohol Use Disorder
|
|
| Jun 22, 2023 |
Adamis Pharmaceuticals Participated in White House Meeting Regarding Opioid Overdose Prevention
|
|
| May 25, 2023 |
Adamis Pharmaceuticals Announces Closing of the Merger with DMK Pharmaceuticals
|
|
| May 19, 2023 |
Adamis Pharmaceuticals Announces Reverse Stock Split
|
|
| May 15, 2023 |
Adamis Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
|
|